by Surgical Synergy Innovation in Keyhole Surgery £498 £1.25 15.0% EIS 3x 2x $45 THOUSAND MILLION EQUITY APPROVED PATENTS FUTURE BILLION Invested to date Fundraise 2016/17 Shareholding Tax effjciency Products Planned Market by 2020
Founder & Inventor One of the world’s pioneering Endoscopic spine surgeons. 2000+ 25+ 32+ 3x Martin Knight Chairman & SURGEONS PUBLISHED PUBLISHED IP Chief Medical Officer PREFORM HIS TECHNIQUES JOURNAL CREDITS NON JOURNAL CREDITS PATENTS Our award winning design partner
TEAM Ieuan Griffiths CEO Potential Distributors Martin Knight Chairman & Roger John Chief Medical Officer CTO
Challenging Times for Healthcare #Healthcare Funding Crisis “This new emphasis on managing and decreasing postoperative patient recovery times could allow laparoscopy to tap into a significantly larger patient pool”. “New medical devices are attempting to provide surgeons with high- efficiency multifunctional devices that cut costs over time.” www.meddeviceonline.com
Endoscopy Laproscopy Looking inside the body to examine Keyhole surgery performed through the interior of a hollow organ or cavity small incisions
Abdominal & Pelvic Surgery Instruments repeatedly changed between access portals Endoscope (Camera) needs to change position Single view-point Blunt or failing instruments Endoscope is rigid. Assistant provides the wrong instrument Challenging ops need more incisions
A Simple Solution Improved Vision - Disposable Tips - Novel Cassette - Always Sharpe CAMERA & LIGHT 6x Tools 3x Patents 2x to follow
Quicker & Less Invasive Operations
HOSPITAL SURGEONS PATIENTS Medusa scope™ Medusa scope™ Medusa scope™ Close up view Fewer incisions Reduces incision 2nd angle of vision Improved patient satisfaction Better patient outcomes Better health outcomes Reduces operating risk Frees up hospital beds Fewer port-site complications 30% quicker instrument change Reduces operation times Less post-operative pain Less surgeon fatigue Fewer infections Faster recovery Tools always sharp Reduce costs
FUNDING FUNDED FUNDING £1.25 MILLION £86k £300k £112k £4 FOUNDER INVESTORS GRANT MILLION PHASE TWO Optimise Design PHASE THREE Market Testing PHASE ONE Clinical Testing Development of Flexible Version Pre-Production Specification Proof of Concept / Working Prototype Small Bore Version Camera Software Development Basic working prototype confirming technical from 6.3mm to 2.8mm Integration to theatre systems feasibility. Refinement of prototype for initial Accreditation FDA USA & Application for accreditation testing completed Q4 2016. CE for Europe 12+ 18 2015 2016 £498k Months Months FUNDING Q3 Q4 TODAY
Use of Funds & Future Goals £62 MILLION sales £20m £28 EBITDA MILLION sales Development of Flexible Version Small Bore Version Optimise Design from 6.3mm to 2.8mm £9.1 Market Testing Accreditation FDA USA & Clinical Testing CE for Europe MILLION Pre-Production Specification sales £9m Camera Software Development EBITDA Integration to theatre systems £1.8 £300 Application for accreditation MILLION £1.7m £212 MILLION EBITDA sales THOUSAND EXIT* sales PHASE TWO PHASE THREE 2021 PHASE ONE 2018 2019 2020 2022 2017 FUNDING ROUND FUNDING ROUND £1.25 £4 MILLION MILLION * Recent exits show 15x EBITDA as an average. Appendix highlights recent acquisitions and exits.
Global Laparoscopy Devices Market (Abdominal cavity surgery only) $16.3 Why is it Growing? BILLION 15 32% Rise in 60+ Age Group 13% 33% Increase in Obesity 2025 Rest of the USA MILLION World $7.9 Advances in Technology Key Hole Surgeries of all Obese People Live in US Lower cost of Key Hole Surgery Performed Globally Fuelling the rise in Bariatrics BILLION Keyhole Surgery 25% Increased Awareness 10% JAPAN EUROPE 2014 33.8% 39% ASIA-Pacifjc 7.5% US Laproscopic Fastest Growing Market Global Laproscopic Device Market 2015 8.6% Instruments Market 2016 CAGR CAGR to 2020 2016 to 2025
TOP 5 COMPETITORS Ethicon, a medical device company of Johnson & Johnson commands 39% of the US market.
by Surgical Synergy THANK YOU
Recommend
More recommend
